Patents
Method for the diagnosis of NASH using metabolic profiles
Centre: OWL GENOMICS - CIC bioGUNE
Date: August 2008
Patent no.: EP08380249.6
Patented in: SPAIN/EUROPE
Exploitation: OWL GENOMICS
Ubiquitin binding polypeptides
Centre: CIC bioGUNE
Date: February 2008 (EPO), February 2009 (USPTO)
Patent no.: EP08380059.9, US 12/389.660
Patented in: SPAIN/EUROPE
Exploitation: Life Sensors
Proteomic Fingerprint for the diagnosis of non-alcoholic steatohepatitis (NASH) and /or steatosis
Centre: OWL GENOMICS-CIC bioGUNE
Date: July 2008
Patent no.: EP08380196.9
Patented in: SPAIN/EUROPE
Exploitation: OWL GENOMICS
Proteínas de fusión de p53 sin actividad de transcripción y sus aplicaciones
Centre: Centro de Investigación Cooperativa en Biociencias - CIC bioGUNE
Date: June 2006
Patent no.: P200601537.0
Patented in: SPAIN
Exploitation: CIC bioGUNE- CI Príncipe Felipe
5’-methylthioadenosine (MTA) as a marker of liver injury
Centre: CIC bioGUNE- University of Vanderbilt
Date: December 2006
Patent no.: US 11/963.691
Patented in: USA
Exploitation: OWL Genomics
SP1 as a marker in diagnosis and prognosis of non-alcoholic steatohepatitis (NASH) and target in drug screening for NASH
Centre: Centro de Investigación Cooperativa en Biociencias - CIC bioGUNE
Date: March 2005
Patent no.: EP05075602.2/EP05077320.9/11/370068
Patented in: SPAIN/EUROPE/USA
Exploitation: OWL Genomics
Diagnostic and Prognostic Methods in Non-Alcoholic Steatohepatitis (Nash)
Centre: Centro de Investigación Cooperativa en Biociencias · CIC bioGUNE
Date: July 2004
Patent no.: EP05780314.0/11/572.562
Patented in: EUROPE/USA
Exploitation: OWL Genomics